Literature DB >> 12239836

Development of monoclonal antibody based antigen capture ELISA to detect chikungunya virus antigen in mosquitoes.

S L Hundekar1, J P Thakare, M D Gokhale, P V Barde, S V Argade, D T Mourya.   

Abstract

BACKGROUND &
OBJECTIVES: Chikungunya (CHIK) virus has caused numerous large outbreaks in India. No active or passive surveillance has been carried out since the last epidemic which occurred in 1971. For active surveillance, it is necessary to have a test, which can detect the virus from a large number of field-collected mosquitoes.
METHODS: The present study describes the standardization of monoclonal antibody (MAb) based antigen capture ELISA to detect chikungunya virus antigen from the mosquitoes. CHIK virus antigen from suspension of experimentally infected mosquitoes and their progeny was captured on mouse polyclonal antibody, while biotinylated CHIK Mab was used as a probing antibody. CHIK virus antigen in the head squashes of virus inoculated mosquitoes was detected using indirect immunofluorescence antibody (IFA) test for confirmation of ELISA results.
RESULTS: The ELISA test was sensitive enough to detect antigen even if a small fraction of a single infected mosquito homogenate was incorporated in the test. The IFA test failed to detect CHIK antigen in 10 and 25 microliters of suspension whereas with ELISA it was detected in all the samples. Progeny of Aedes aegypti and Ae. albopictus mosquitoes infected with chikungunya virus did not show the possibility of existence of transovarial transmission. INTERPRETATION &
CONCLUSION: This test is rapid and simple since it can be completed in two days as compared to the conventional mosquito inoculation and IFA techniques, which require at least 10 days. There is an additional advantage with this test that a large number of samples can be processed, and the remaining homogenate of the mosquitoes can be used for screening other viruses. Experimental data raised using this test showed that transovarial transmission of this virus does not occur in these vector species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239836

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  7 in total

1.  Rapid and real-time detection of Chikungunya virus by reverse transcription loop-mediated isothermal amplification assay.

Authors:  M M Parida; S R Santhosh; P K Dash; N K Tripathi; V Lakshmi; N Mamidi; A Shrivastva; N Gupta; P Saxena; J Pradeep Babu; P V Lakshmana Rao; Kouichi Morita
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

Review 2.  Chikungunya: a potentially emerging epidemic?

Authors:  Michelle M Thiboutot; Senthil Kannan; Omkar U Kawalekar; Devon J Shedlock; Amir S Khan; Gopalsamy Sarangan; Padma Srikanth; David B Weiner; Karuppiah Muthumani
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

3.  Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications.

Authors:  Rajpal S Kashyap; Shweta H Morey; Nitin H Chandak; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Cerebrospinal Fluid Res       Date:  2010-08-13

4.  Reemergence of Chikungunya virus in Indian Subcontinent.

Authors:  C V M Naresh Kumar; D V R Sai Gopal
Journal:  Indian J Virol       Date:  2010-09-03

5.  Chikungunya outbreaks caused by African genotype, India.

Authors:  Prasanna N Yergolkar; Babasaheb V Tandale; Vidya A Arankalle; Padmakar S Sathe; A B Sudeep; Swati S Gandhe; Mangesh D Gokhle; George P Jacob; Supriya L Hundekar; Akhilesh C Mishra
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

6.  An outbreak of chikungunya in Jamshedpur, Jharkhand in 2011.

Authors:  Y K Gurav; V Gopalkrishna; P S Shah; D R Patil; M Mishra; M S Paingankar; A Singh; P S Sathe; A C Mishra
Journal:  Indian J Med Res       Date:  2012-11       Impact factor: 2.375

7.  Clinical features and molecular diagnosis of Chikungunya fever from South India.

Authors:  Vemu Lakshmi; Mamidi Neeraja; M V S Subbalaxmi; M M Parida; P K Dash; S R Santhosh; P V L Rao
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.